LAMC2 and pancreatic intraductal papillary-mucinous neoplasm: This study also corroborates evidence for individual candidate biomarkers of high-risk IPMN, including CD55, laminin subunit gamma 2 (LAMC2), amphiregulin (AREG), and others.